Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Behavioral Health Care Software And Services Market
5.1. COVID-19 Landscape: U.S. Behavioral Health Care Software And Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global U.S. Behavioral Health Care Software And Services Market, By Component
8.1. U.S. Behavioral Health Care Software And Services Market, by Component, 2022-2030
8.1.1. Software
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Support Services
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global U.S. Behavioral Health Care Software And Services Market, By Function
9.1. U.S. Behavioral Health Care Software And Services Market, by Function e, 2022-2030
9.1.1. Clinical
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Administrative
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Financial
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global U.S. Behavioral Health Care Software And Services Market, By Delivery Model
10.1. U.S. Behavioral Health Care Software And Services Market, by Delivery Model, 2022-2030
10.1.1. Ownership
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Subscription
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global U.S. Behavioral Health Care Software And Services Market, By End-use
11.1. U.S. Behavioral Health Care Software And Services Market, by End-use, 2022-2030
11.1.1. Providers
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Payers
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Patients
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global U.S. Behavioral Health Care Software And Services Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.2. Market Revenue and Forecast, by Function (2017-2030)
12.1.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.1.4. Market Revenue and Forecast, by End-use (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Function (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Function (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.2. Market Revenue and Forecast, by Function (2017-2030)
12.2.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.2.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Function (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Function (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Function (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Function (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.2. Market Revenue and Forecast, by Function (2017-2030)
12.3.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.3.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Function (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Function (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Function (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Function (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.2. Market Revenue and Forecast, by Function (2017-2030)
12.4.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.4.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Function (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Function (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Function (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Function (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.2. Market Revenue and Forecast, by Function (2017-2030)
12.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Function (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Function (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Delivery Model (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 13. Company Profiles
13.1. Cerner Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Core Solutions, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Epic
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Meditab
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Holmusk
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Netsmart Technologies
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Qualifacts Systems, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Welligent, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. SimplePractice, LLC
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. TherapyNotes, LLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms